Numerous studies have highlighted the involvement of m6A regulators in a wide range of human diseases, spanning psychiatric disorders, metabolic diseases, cardiovascular diseases, as well as specific cancers such as AML, brain tumors, bladder cancer, ovarian cancer, etc. [39–45] (Table 1). Here, METTL3 is linked to acute myeloid leukemia.